Study of the Efficacy and Safety of Bupivacaine TTS Patch in Patients With Chronic Low Back Pain
Public ClinicalTrials.gov record NCT01096966. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Bupivacaine TTS (Bupivacaine Patch) in Patients With Chronic Low Back Pain
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the efficacy and safety of Bupivacaine TTS (Bupivacaine patch) compared to placebo in patients with chronic low back pain.
Study identification
- NCT ID
- NCT01096966
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 263 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2010
- Primary completion
- Jan 31, 2011
- Completion
- Jan 31, 2011
- Last update posted
- Jun 14, 2022
2010 – 2011
United States locations
- U.S. sites
- 21
- U.S. states
- 12
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Tempe | Arizona | 85283 | — |
| Not listed | La Mesa | California | 91942 | — |
| Not listed | Torrance | California | 90502 | — |
| Not listed | Fort Lauderdale | Florida | 33306 | — |
| Not listed | Gainesville | Florida | 32605 | — |
| Not listed | Longwood | Florida | 32779 | — |
| Not listed | West Palm Beach | Florida | 33409 | — |
| Not listed | Marietta | Georgia | 30060 | — |
| Not listed | Newnan | Georgia | 30265 | — |
| Not listed | Springfield | Massachusetts | 01103 | — |
| Not listed | St Louis | Missouri | 63141 | — |
| Not listed | New York | New York | 10004 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Oklahoma City | Oklahoma | 73109 | — |
| Not listed | Allentown | Pennsylvania | 18103 | — |
| Not listed | Altoona | Pennsylvania | 16602 | — |
| Not listed | Philadelphia | Pennsylvania | 19139 | — |
| Not listed | Austin | Texas | 78756 | — |
| Not listed | Dallas | Texas | 75231 | — |
| Not listed | Houston | Texas | 77074 | — |
| Not listed | Richmond | Virginia | 23294 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01096966, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 14, 2022 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01096966 live on ClinicalTrials.gov.